Arsenic trioxide-mediated cytotoxicity and apoptosis inprostate and ovarian carcinoma cell lines

Clinical Cancer Research

Volumn 6, Issue 12, 2000, Pages 4957-4964

  Uslu, R ^a   Sanli, U A ^a   Sezgin, C ^a   Karabulut, B ^a   Terzioglu, E ^a   Omay, S B ^a   Goker, E ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; BUTYLATED HYDROXYANISOLE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; SUPEROXIDE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MORTALITY; OVARY CARCINOMA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROSTATE CARCINOMA; TREATMENT PLANNING;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; APOPTOSIS; ARSENICALS; BUTYLATED HYDROXYANISOLE; CARCINOGENS; CISPLATIN; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETOPOSIDE; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; OVARIAN NEOPLASMS; OXIDES; PROSTATIC NEOPLASMS; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0034490080     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cancer statistics 1996
2. Cancer statistics 1995
3. Drug resistance: An overview of the current state of the art
4. Management of epithelial ovarian cancer
5. Studies on prostatic cancer II: The effect of castration on clinical patients with carcinoma of the prostate
6. Management of relapsing disease in prostate cancer
7. Arsenic: New life for an old potion
8. Use of arsenic trioxide in the treatment of APL. Clinical efficacy and pharmacokinetics
9. Differential cytotoxic effects of arsenic on human and animal cells
10. 3 induces NB4 cell apoptosis with downregulation of bcl-2 expression and modulation of PML-RARα/PML protein
11. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARα independent manner
12. Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines
13. Arsenic trioxide induces apoptosis of oesophageal carcinoma in vitro
14. Chemosensitization of human prostate carcinoma cell lines to anti-Fas-mediated cytotoxicity and apoptosis
15. Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors
16. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/Apo-1) independently of its ligand CD95L
17. Criteria for analyzing interactions between biologically active agents
18. Butylate hydroxyanisole: In perspective
19. Interaction of BHA with mitochondrial oxidative phosphorylation
20. Effect of BHA on electron transport in rat liver mitochondria
21. Comparative studies on effect of butylate hydroxyanisole on gluthathione and gluthathione-S-transferases in the tissues of male and female mice
22. Increase in γ-glutamyl-cysteinesynthetase activity as a mechanism for butylate hydroxyanisole-mediated elevation of hepatic glutathione
23. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells
24. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway
25. Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells